Natural killer cell activity as a biomarker for the diagnosis of lung cancer in high-risk patients.

Morten Borg Sara Witting Christensen WenTorben Frøstrup HansenAnders JakobsenRikke Fredslund AndersenOle HilbergUlla Møller WeinreichLine Nederby

Published in: The Journal of international medical research (2022)

The significantly lower NKA in patients with late-stage lung cancer warrants further investigation combining NKA with other biomarkers and examining the potential role of NKA as a marker of disseminated disease.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
cell therapy
mesenchymal stem cells
bone marrow